UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB


(Mark One)
            |X|  QUARTERLY REPORT UNDER SECTION 13 OR 15(D)
                 OF THE SECURITIES EXCHANGE ACT OF 1934

                       For the quarterly period ended September 30, 2004

            [ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(D)
                 OF THE EXCHANGE ACT

           For the transition period from ______________ to ______________


                        Commission file number  000-30697


                            PERFECT HEALTH CARE CORP.
           ----------------------------------------------------------
           (Exact name of small business as specified in its charter)


             NEVADA                                     48-1302159
----------------------------------------    ------------------------------------
   (State or other jurisdiction of           (IRS Employer Identification No.)
    incorporation or organization)


                  4017 Colby Avenue, Everett, Washington 98201
          -----------------------------------------------------------
                    (Address of principal executive offices)


                                 (425) 258-4222
                           --------------------------
                           (Issuer's telephone number)


  ----------------------------------------------------------------------------
              (Former name, former address, and former fiscal year,
                         if changed since last report)


                                      -i-
<PAGE>

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.  Yes |X|     No [ ]

                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Check whether the registrant filed all documents and reports required to be
filed by Section 12, 13, or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by the court.   Yes [ ]     No [ ]

                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:

     As of January 1, 2005, 23,511,000 shares common stock, $0.001 par value

Transitional Small Business Disclosure Format (Check one):  Yes  [ ]    No  |X|

                                      -ii-
<PAGE>


                         PART 1 - FINANCIAL INFORMATION

ITEM 1  -  FINANCIAL STATEMENTS

In the opinion of management, the accompanying unaudited financial statements
included in this Form 10-QSB reflect all adjustments necessary for a fair
presentation of the results of operations for the periods presented. The results
of operations for the periods presented are not necessarily indicative of the
results to be expected for the full year.




                                      -1-
<PAGE>

                            PERFECT HEALTH CARE CORP.
                                  Balance Sheet
                                   (Unaudited)


<TABLE>
<CAPTION>

                                                                   September 30,      June 30,
                  Assets                                                 2004            2004
                                                                   -------------   -------------
Current Assets

<S>                                                                    <C>             <C>
      Cash and cash equivalents                                     $    15,963     $    27,872
      Accounts receivable, net of allowance for doubtful accounts        34,964          41,343
      Prepaid expenses                                                      999           1,440
                                                                   -------------   -------------

                                              Total Current Assets       51,926          70,655


Property and Equipment

      Office furniture and equipment                                     13,729          13,729
      Vehicles                                                            6,064           6,064
      Leasehold improvements                                              8,611           7,703
      Less - accumulated depreciation                                    (6,390)         (5,486)
                                                                   -------------   -------------

                                        Net Property and Equipment       22,014          22,010

           Total Assets                                             $    73,940     $    92,665
                                                                   =============   =============

           Liabilities and Stockholders' Equity (Deficit)

Current Liabilities

      Accounts payable and accrued liabilities                      $   113,260     $    87,553
      Deferred revenue                                                   41,466          58,043
      Accrued compensation                                               96,950          83,450
      Advances by stockholders and directors                            339,723         273,578
                                                                   -------------   -------------

                                         Total Current Liabilities      591,399         502,624

Stockholders' Equity (Deficit)

      Preferred stock
           $.001 par value; 25,000,000 shares authorized,
           1,600,000 shares issued and outstanding                        1,600           1,600
      Common Stock
           $.001 par value; 200,000,00 shares authorized,
           23,511,000 and 23,066,000 shares issued and
           outstanding at June 30, 2004 and 2003, respectively           23,511          23,511
      Additional Paid-in Capital                                        611,189         611,189
      Less stock subscriptions receivable                                (7,500)         (7,500)
      Retained earnings (deficit)                                    (1,146,259)     (1,038,759)
                                                                   -------------   -------------

           Total Liabilities and Stockholders' Equity (Deficit)        (517,459)       (409,959)
                                                                   -------------   -------------

                               Total Stockholders' Equity (Deficit) $    73,940     $    92,665
                                                                   =============   =============
</TABLE>


              See accompanying notes to the financial statements.


                                      -2-
<PAGE>

                            PERFECT HEALTH CARE CORP.
                            Statements of Operations
                                   (Unaudited)




<TABLE>
<CAPTION>
                                                           September 30,    September 30,
                                                               2004             2003
                                                           -------------    -------------

<S>                                                            <C>              <C>
Revenue from Card Sales                                     $    19,392      $    33,097

Cost of Card Sales                                               15,517           11,267
                                                           -------------    -------------

Gross Profit                                                      3,875           21,830

Expenses
       Selling, general and administrative expense              110,471          250,286
       Depreciation                                                 904            1,130
                                                           -------------    -------------

                                            Total Expenses      111,375          251,416

                                                  Net Loss  $  (107,500)     $  (229,586)
                                                           =============    =============


Net Loss per Common Share                                       $ (0.00)         $ (0.01)
                                                           =============    =============

Weighted Average Common Shares Outstanding                   23,511,000       23,285,330
                                                           =============    =============
</TABLE>


              See accompanying notes to the financial statements.


                                      -3-
<PAGE>

                            PERFECT HEALTH CARE CORP.
                            Statements of Cash Flows
                                   (Unaudited)



<TABLE>
<CAPTION>
                                                                        Sept 30, 2004   Sept 30, 2003
                                                                        -------------   -------------
Operating Activities
<S>                                                                       <C>             <C>
    Net Loss                                                             $  (107,500)    $  (229,586)
       Adjustments to reconcile net loss to cash used
          by operating activities:
          Depreciation                                                           904           1,130
          Provision for bad debts                                                  -               -
          Preferred stock issued for services rendered                             -               -
          Changes in operating assets and liabilities
             (Increase) decrease in accounts receivable                        6,379           7,254
             (Increase) decrease in prepaid expenses                             441           3,536
             Increase (decrease) in accounts payable
               & accrued liabilities                                          25,707          (1,316)
             Increase (decrease) in accrued compensation                      13,500          27,250
             Increase (decrease) in advance by stockholders/directors         (6,855)          8,951
             Increase (decrease) in deferred revenue                         (16,577)        (14,315)
                                                                        -------------   -------------
                                    Cash used by Operating Activities        (84,001)       (197,096)

Investing Activities
    Purchase of property and equipment                                          (908)         (2,062)
                                                                        -------------   -------------

                                   Net cash from Investing Activities           (908)         (2,062)

Cash Flows from Financing Activities
       Proceeds from sales of common stock                                         -               -
       Payments of stock subscriptions, net                                        -          65,000
       Advances by stockholders/directors                                     73,000               -
                                                                        -------------   -------------

                                   Net cash from Financing Activities         73,000          65,000
                                                                        -------------   -------------

Net increase (decrease) in cash                                              (11,909)       (134,158)

Cash at beginning of period                                                   27,872         246,516
                                                                        -------------   -------------

Cash at end of period                                                    $    15,963     $   112,358
                                                                        =============   =============

Cash paid for income taxes                                               $         -     $         -
                                                                        =============   =============

Cash paid for interest                                                   $         -     $         -
                                                                        =============   =============
</TABLE>



              See accompanying notes to the financial statements.


                                      -4-
<PAGE>

                            PERFECT HEALTH CARE CORP.
                          NOTES TO FINANCIAL STATEMENTS

                               September 30, 2004


A.  BASIS OF PRESENTATION

The Interim financial statements of Perfect Health Care Corp. (the Company) for
the three months ended September 30, 2004 are not audited. The financial
statements are prepared in accordance with the requirements for unaudited
interim periods, and consequently do not include all disclosures required to be
in conformity with accounting principles generally accepted in the United States
of America.

In the opinion of management, the accompanying financial statements contain all
adjustments, consisting only of normal recurring accruals, necessary for a fair
presentation of the Company's financial position as of September 30, 2004 and
the results of operations and cash flows for the three months ended September
30, 2004.

The results of operations for the three months ended September 30, 2004 are not
necessarily indicative of the results for a full year period.


B.  SIGNIFICANT ACCOUNTING POLICIES

     (a)  Accounting methods

     These consolidated financial statements were prepared on an accrual method
     of accounting.

     (b)  Use of Estimates

     The preparation of consolidated financial statements in conformity with
     generally accepted accounting principles requires management to make
     estimates and assumptions that affect the reported amount of assets and
     liabilities and disclosure of contingent assets and liabilities at the date
     of the financial statements and the reported amounts of revenues and
     expenses during the reporting period. Actual results could differ from
     those estimates.

     (c)  Revenue Recognition

     The Company sells the Card either through annual contracts with customer
     payment due at the time the contract is executed or on a month-to-month
     basis with payment due each month. Revenue from the sale of annual
     contracts is deferred and recognized on a straight line basis over the
     contractual term. Revenue related to month-to-month agreements is
     recognized as payments are received from the customers. Customers have the
     right to a refund of only their unamortized portion of the annual contract.
     Month-to-month agreements have no refund rights.



                                      -5-
<PAGE>

     (d)  Loss Per Share

     Loss per share is based on the weighted average number of shares
     outstanding during the period. The Company adopted SFAS No. 128, "Earnings
     Per Share."

     (e)  Income Taxes

     The Company has adopted SFAS No. 109 "Accounting for Income Taxes". The
     Company accounts for income taxes under an asset and liability approach
     that requires the recognition of deferred tax assets and liabilities for
     the expected future tax consequences of events that have been recognized in
     the Company's financial statements or tax returns.

     In estimating future tax consequences, all expected future events, other
     than enactment of changes in the tax laws or rates, are considered.

     Due to the uncertainty regarding the Company's future profitability, the
     future tax benefits of its losses have been fully reserved and no net tax
     benefit has been recorded in these financial statements.

     (f)  Fair Value of Financial Instruments

     The respective carrying value of certain on-balance-sheet financial
     instruments approximated their fair values. These financial instruments
     include cash, tax credit recoverable, reclamation bond, loan receivable,
     accounts payable and accrued liabilities, amount due to a director and loan
     payable. Fair values were assumed to approximate fair values or they are
     receivable or payable on demand. Management is of the opinion that the
     Company is not exposed to significant interest, credit or currency risks
     arising from these financial instruments.



ITEM 2 - MANAGEMENT DISCUSSION AND ANALYSIS

     The following discussion and analysis should be read in conjunction with
our un audited financial statements for the three month period ended September
30, 2004.

Introduction

     We are engaged in the marketing and administration of membership programs
that entitle our members (also called "cardholders") to receive discounted rates
on medical and related products and services when they purchase for cash without
the aid of insurance. Our principal product is the Primary Care Card which, for
a fee of $49 per month, permits the cardholder to obtain discounts ranging from
5% to nearly 70% off the regular pricing schedules when they purchase services


                                      -6-
<PAGE>

from providers who are members of our provider networks. Services can include
primary care, medical specialists, radiology, physical therapy, hospitalization,
pharmaceutical, prostheses, vision care, chiropractic, alternative medicine
treatments, medical evacuation, patient advocacy, and others. Other Card
products, offered at lesser prices, provide discounts on varying combinations of
services with varying rates of discounts.

     To date, our greatest challenge has been establishing a market for our
offerings. Since inception, we have focused our limited resources largely on
negotiating the provider agreements needed to package what we think are
exceptional products, but we have yet to demonstrate any meaningful degree of
market acceptance for those products. Ongoing discussions with insurance
industry executives have indicated that our Card products may be successfully
"bundled" with conventional insurance products, however we have yet to
consummate such a marketing partnership. Our contract with UIS (see "Item 1 -
Description of Business", above) has yielded some encouraging sales results
marketing the Card as a stand-alone product. And representatives of various
established marketing and sales representative organizations encountered at
trade shows have resulted in some re-seller agreements, but none as yet have had
significant success in marketing our Card products. Our own sales efforts based
on local television and print advertising have yielded some sales, but we
currently lack the resources to exploit these successes.

Results Of Operations For the Three Months Ended September 30, 2004 vs. 2003

     Since our inception, we have funded our activities primarily by issuing
stock and borrowing. Although we will continue periodically to seek external
sources of funds, there can be no assurance that we will be able to raise
sufficient capital to fund our operations. If we do raise equity capital,
depending on the number of shares issued and the issue price of the shares,
current shareholders' interests may be diluted.

     During the fiscal year ended June 30, 2004, our first full fiscal year of
operation, we raised $29,000 from sales of equity stock, and received $190,000
in advances from officers and directors. The stock sales were sales of our $.001
par value common stock made without registration under the Securities Act of
1933 (the "Act"), pursuant to a private placement under Regulation D of the Act.
During the quarter ended September 30, 2004 we received and additional $73,000
in advances from officers and directors.

     For the quarter ended September 30, 2004 we had revenues of $19,392 versus
$33,097 for the same period in 2003. Expenses for the period were $111,375 vs.
$251,416, which included accrued executive compensation of $13,500 and $27,250,
respectively. The reductions in both revenues and expenses are attributable to a
scaling back of our administrative staff and direct marketing activities
somewhat as we focus on establishing and further developing reseller
arrangements with established marketing organizations.



                                      -7-
<PAGE>

     The Company's consolidated financial statements were prepared on a going
concern basis, which assumes that the Company will be able to realize assets and
discharge liabilities in the normal course of business. Our independent auditors
included in their report for the period ended June 30, 2004 cautionary language
indicating substantial doubt as to the company's ability to continue as a going
concern. The ability to continue as a going concern is dependent on our ability
to generate profitable operations in the future, to maintain adequate financing,
and to achieve a positive cash flow. There is no assurance we will be able to
meet all or any of such goals.

Revenue Recognition Policy

     Currently, all of our Card products are sold as renewable annual
memberships, for which we receive either monthly payments or a discounted
payment in advance for the entire term. Where we receive monthly payments, we
recognize revenue each month as we receive the payments. In the case of pre-paid
memberships, we defer both the revenue and the cost, recognizing them pro-rata
over the succeeding periods for the period of the membership.


Liquidity and Capital Resources

     At September 30, 2004 we had cash and cash equivalents of $15,963, and
accounts receivable (net of doubtful accounts) of $34,964. We have reduced our
administrative expenses compared to the prior year, but at our present levels of
revenues and expenses we expect our available funds to support our operations
for only about three months into the future. In the past year we have met our
expenses in part through advances from certain directors and executive officers,
but the individuals are not obligated to continue to make such advances. We have
no lines of credit or other sources of cash, and expect to find it necessary to
raise additional capital before during the next twelve months, probably through
a private sale of our common stock. We expect revenues from our UIS/Quixtar
remarketing agreement to continue to increase, although not to a level
sufficient to cover our expenses for the foreseeable future.


ITEM 3  -  CONTROLS AND PROCEDURES

     An evaluation was carried out under the supervision and with the
participation of the Company's management, including its Chief Executive Officer
and Chief Financial Officer, of the effectiveness of the disclosure controls and
procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934,
as amended). Based on that evaluation, the Chief Executive Officer and Chief
Financial Officer concluded that the disclosure controls and procedures were
effective as of the end of the period covered by this report.

     No change in the Company's internal control over financial reporting (as
defined in Rule 14-15f) of the Securities Exchange Act of 1934, as amended)
occurred during the period covered by this report that has materially affected,
or is reasonably likely to materially affect, the Company's internal control
over financial reporting.


                                      -8-
<PAGE>

                           PART II - OTHER INFORMATION



ITEM 6  -  EXHIBITS AND REPORTS ON FORM 8-K


Exhibits

       Exhibit No.                 Description
     ----------------          -------------------------------------------

          31.1                 Certification of CEO / CFO (Section 302)
          32.1                 Certification of CEO / CFO (Section 302)




                                   SIGNATURES

     In accordance with the requirements of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                                     PERFECT HEALTH CARE CORP.


February 15, 2005                    /s/ Antoine Jarjour
                                     -----------------------------------------
                                     President, Acting Chief Financial Officer




                                      -9-